{'fraction_non_alphanumeric': 0.03315881326352531, 'fraction_numerical': 0.0017452006980802793, 'mean_word_length': 5.597701149425287, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Resveratrol Exerts Dose‐response Anti‐fibrotic and Pro‐fibrotic Effect in Renal Tubular Epithelial Cells

Renal fibrosis is the common pathological feature of chronic kidney disease (CKD) that finally leads to end‐stage renal disease (ESRD) and renal failure. Resveratrol (RSV) has been widely used as nutrition supplement for metabolic diseases and anti‐cancer therapy, but its potential risk on kidney health has not been fully evaluated. In this study, we investigated the comprehensive effect of RSV on renal fibrosis in human tubular epithelial cells (TECs) line HK‐2.